Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Retinal Vein Occlusion With Macular Edema”

133 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 133 results

Testing effectiveness (Phase 2)Study completedNCT04667910
What this trial is testing

601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)

Who this might be right for
Central Retinal Vein Occlusion
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 60
Large-scale testing (Phase 3)Study completedNCT01198327
What this trial is testing

Extended Follow-up of Patients With Macular Edema Due to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Peter A Campochiaro, MD 66
Post-approval studies (Phase 4)Study completedNCT01710839
What this trial is testing

Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion

Who this might be right for
Central Retinal, Hemi Retinal & Brach Retinal Vein Occlusions
Charles C Wykoff, PhD, MD 30
Large-scale testing (Phase 3)Study completedNCT04264819
What this trial is testing

Study of Brolucizumab in Adult Patients With Suboptimal Anatomically Controlled Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration
Novartis Pharmaceuticals 295
Post-approval studies (Phase 4)Study completedNCT01027481
What this trial is testing

Ranibizumab in Patients With Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Medical University of Vienna 30
Post-approval studies (Phase 4)Study completedNCT02953938
What this trial is testing

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety

Who this might be right for
Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)
Novartis Pharmaceuticals 59
Large-scale testing (Phase 3)Ended earlyNCT00500045
What this trial is testing

Retrospective Study of the Effectiveness and Safety of Niacin and Steroid Eye Drops for Retinal Vein Occlusions

Who this might be right for
Central Retinal Vein OcclusionBranch Retinal Vein Occlusion
Palo Alto Medical Foundation 36
Not applicableUnknownNCT01581151
What this trial is testing

Ozurdex With Rescue Lucentis for Treating Macular Edema Secondary to Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusion
Brian Burke, MPH 30
Not applicableStudy completedNCT04812977
What this trial is testing

Comparison of Intravitreal Anti-VEGF Versus Combination Therapy in Central Retinal Vein Occlusion

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
Hayatabad Medical Complex 30
Post-approval studies (Phase 4)Study completedNCT01903720
What this trial is testing

A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Allergan 71
Large-scale testing (Phase 3)UnknownNCT01635803
What this trial is testing

Comparing the Effectiveness and Costs of Bevacizumab to Ranibizumab in Patients With Retinal Vein Occlusions (BRVO)

Who this might be right for
Retinal Vein Occlusion
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 296
Large-scale testing (Phase 3)Study completedNCT00485836
What this trial is testing

The Efficacy and Safety of Ranibizumab Injection in Patients With Macular Edema Secondary to Central Retinal Vein Occlusion (CRUISE)

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Genentech, Inc. 392
Not applicableStudy completedNCT04499703
What this trial is testing

Evaluation of the Retinal Health Monitoring System Thickness Module

Who this might be right for
Macular EdemaMacular Degeneration
Kubota Vision Inc. 60
Post-approval studies (Phase 4)Study completedNCT01085734
What this trial is testing

Single Site, Masked, Randomized, Controlled Study to Assess Efficacy of Osurdex as Adjunct to Avastin Compared With Avastin Alone in the Treatment of Patients With Macular Edema Due to Central or Branch Retinal Vein Occlusion

Who this might be right for
Retinal Vein Occlusions
Maturi, Raj K., M.D., P.C. 30
Post-approval studies (Phase 4)UnknownNCT03405376
What this trial is testing

Prospective Trial of Treat and Extend Aflibercept for Macular Edema Secondary to Branch Retinal Vein Occlusion

Who this might be right for
Branch Retinal Vein Occlusion With Macular Edema
Yeungnam University College of Medicine 49
Not applicableUnknownNCT02091505
What this trial is testing

Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO

Who this might be right for
Central Retinal Vein Occlusion
Mie University 30
Large-scale testing (Phase 3)Active Not RecruitingNCT04444492
What this trial is testing

Combination of Ranibizumab and Targeted Laser Photocoagulation

Who this might be right for
Central Retinal Vein Occlusion With Macular Edema
University of Giessen 88
Post-approval studies (Phase 4)Study completedNCT01277302
What this trial is testing

A Study Evaluating Dosing Regimens for Treatment With Intravitreal Ranibizumab Injections in Subjects With Macular Edema Following Retinal Vein Occlusion

Who this might be right for
Macular Edema
Genentech, Inc. 202
Large-scale testing (Phase 3)Study completedNCT01969708
What this trial is testing

Study of Comparative Treatments for Retinal Vein Occlusion 2 (SCORE2)

Who this might be right for
Central Retinal Vein Occlusion
The Emmes Company, LLC 362
Post-approval studies (Phase 4)Study completedNCT06708624
What this trial is testing

Ocular Safety and Usability Study for FYB201 PFS

Who this might be right for
Age-Related Macular DegenerationBranch Retinal Vein Occlusion with Macular EdemaCentral Retinal Vein Occlusion with Macular Edema
Formycon AG 31
Load More Results